| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/27/2009 | WO2008157776A8 Modified diphtheria toxins |
| 08/27/2009 | WO2008140477A3 Hybrid immunoglobulins with moving parts |
| 08/27/2009 | WO2006096834A3 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 08/27/2009 | US20090217424 Constitutive promoters from poplar and uses thereof |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090217391 T1r3 a novel taste receptor |
| 08/27/2009 | US20090216004 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215989 Heterologous Protein Production Using The Twin Arginine Translocation Pathway |
| 08/27/2009 | US20090215987 Peptide amidation process |
| 08/27/2009 | US20090215691 NOGO Receptor Antagonists |
| 08/27/2009 | US20090215679 Disease-associated proteins |
| 08/27/2009 | US20090215667 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants |
| 08/27/2009 | US20090215663 Savinase variants having an improved wash performance on egg stains |
| 08/27/2009 | US20090215146 Method for Producing Virus-Type Particles Containing an Active Substance |
| 08/27/2009 | US20090215122 Process for Producing Thioredoxin |
| 08/27/2009 | US20090215121 Process for Preparing High Levels of Interferon Beta |
| 08/27/2009 | US20090215120 The Use of Protein S Fusion for Protein Solubilization |
| 08/27/2009 | US20090215119 Methods for producing specific binding pairs |
| 08/27/2009 | US20090215118 D-aminoacylase |
| 08/27/2009 | US20090215117 Site specific incorporation of keto amino acids into proteins |
| 08/27/2009 | US20090215116 Identification of a beta-1,3-N-acetylgalactosaminyltransferase (CGTE) from campylobacter jejuni LIO87 |
| 08/27/2009 | US20090215115 Sialyltransferases comprising conserved sequence motifs |
| 08/27/2009 | US20090215114 Method of enzymatically synthesizing 3' -phosphoadenosine-5' -phosphosulfate |
| 08/27/2009 | US20090215113 Methods for purifying pertussis toxin and peptides useful therefor |
| 08/27/2009 | US20090215076 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/27/2009 | US20090215049 Novel litaf binding site peptides and methods of using the same |
| 08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
| 08/27/2009 | US20090215042 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
| 08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
| 08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 08/27/2009 | US20090214579 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 08/27/2009 | US20090214574 Anti-cd16 binding molecules |
| 08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
| 08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
| 08/27/2009 | US20090214559 Therapeutic Human Anti-IL-1R1 Monoclonal Antibody |
| 08/27/2009 | US20090214534 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY |
| 08/27/2009 | US20090214528 Host cell lines for production of antibody constant region with enhanced effector function |
| 08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 08/27/2009 | US20090214513 Mammalian expression systems |
| 08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
| 08/27/2009 | US20090214476 Novel mannose-specific adhesins and their use |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | US20090211893 Photo-Activatable Amino Acids |
| 08/27/2009 | CA2715237A1 Virus-like particles as vaccines for paramyxovirus |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093286A1 Multi-chain eukaryotic display vectors and uses thereof |
| 08/26/2009 | EP2093237A1 Cancer therapeutic agent comprising anti-hb-egf antibody as active ingredient |
| 08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
| 08/26/2009 | EP2091969A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/26/2009 | EP1624891B1 Clotting factor-fc chimeric proteins to treat hemophilia |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1299524B1 Human myeloma cell line |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1200592B1 Mammalian cytokines; related reagents |
| 08/26/2009 | EP1147212B1 T helper cell epitopes |
| 08/26/2009 | EP1066324B1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 08/26/2009 | EP1037977B1 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/26/2009 | EP1025218B9 Libraries of human antibody polypetides |
| 08/26/2009 | EP0774120B1 Peptides marked with metal chelates |
| 08/26/2009 | CN101517073A Process for enzymatic hydrolysis of pretreated lignocellulosic feedstocks |
| 08/26/2009 | CN101516913A Antibody having enhanced ADCC activity and method for production thereof |
| 08/26/2009 | CN101516901A Genetically programmed expression of selectively sulfated proteins in eubacteria |
| 08/26/2009 | CN101514355A Method for preparing wheat germ protein ACE inhibitory peptide by continuous enzymolysis and ultra-filtration separation coupling |
| 08/26/2009 | CN101514354A Sea cucumber polypeptide, preparation method and application thereof |
| 08/26/2009 | CN101514232A RANKL-Fc fusion protein, preparation method and application thereof |
| 08/26/2009 | CN100532561C New glucoamylase and nucleic acid sequence coding same |
| 08/26/2009 | CN100532558C Optimizing glycan processing in plants |
| 08/25/2009 | US7579515 Use of the present invention will enhance proper timing; if the switch increases ovulation >2.4-fold, oocyte production can be achieved even more efficiently, creating major benefits for the transgenic/cloning industry |
| 08/25/2009 | US7579448 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579446 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 08/25/2009 | US7579441 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo |
| 08/25/2009 | US7579187 Anti-A33 antibody |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579171 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | US7579167 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof |
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | US7579165 Modified by immobilizing with disulfide-containing compound; mass spectrometry; solid phase synthesis |
| 08/25/2009 | US7579011 isolated polypeptide use in vaccines against A. salmonicida infections such as fish disease furunculosis |
| 08/25/2009 | US7579007 Production of “biological carriers” for induction of immune responses and inhibition of viral replication |
| 08/25/2009 | US7578998 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2309600C Low-temperature inducible expression vector |
| 08/25/2009 | CA2157476C Mutant luciferases |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101737A1 Protein expression vector tagged with peptide having methionine residue |
| 08/20/2009 | WO2009101672A1 Fused protein containing insulin precursor of overexpression and secretion type, dna encoding the same and method of producing insulin |
| 08/20/2009 | WO2009101178A1 Enzymatic conjugation of bioactive moieties |
| 08/20/2009 | WO2009101146A1 Fish protein hydrolysate having a bone-stimulating and ‑maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/20/2009 | WO2009101134A1 Fish protein hydrolysate having a satietogenic activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 08/20/2009 | WO2009075825A3 Translocation and mutant tnk1 kinase in human lymphoma |